Clinical Trial Update: The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy

View source ↗

Summary

This clinical trial update examines the prognostic impact of HER2 expression in non-metastatic HER2-positive breast cancer treated with dual HER2-targeted thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dual HER2-targeted therapy

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Breast Cancer, HER2/CEP17 Ratio | Status: RECRUITING